X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (610180) 610180
Newspaper Article (60516) 60516
Newsletter (52009) 52009
Magazine Article (3282) 3282
Conference Proceeding (2949) 2949
Book Chapter (2799) 2799
Dissertation (1906) 1906
Web Resource (826) 826
Publication (717) 717
Trade Publication Article (634) 634
Reference (228) 228
Book / eBook (193) 193
Government Document (140) 140
Transcript (80) 80
Book Review (55) 55
Journal / eJournal (38) 38
Paper (35) 35
Streaming Video (21) 21
Report (14) 14
Standard (12) 12
Data Set (1) 1
Library Holding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
glucose (330356) 330356
humans (248087) 248087
male (188104) 188104
animals (175921) 175921
female (152686) 152686
diabetes (119159) 119159
dextrose (114632) 114632
adult (91646) 91646
glucose - metabolism (87421) 87421
insulin (87389) 87389
middle aged (81762) 81762
rats (80178) 80178
glucose metabolism (79505) 79505
blood glucose - metabolism (77966) 77966
endocrinology & metabolism (77363) 77363
research (74760) 74760
metabolism (58452) 58452
blood glucose - analysis (57236) 57236
insulin resistance (54164) 54164
mice (49329) 49329
aged (48756) 48756
analysis (48380) 48380
physiological aspects (46609) 46609
insulin - blood (44536) 44536
obesity (44372) 44372
biochemistry & molecular biology (43564) 43564
risk factors (37876) 37876
type 2 diabetes (37036) 37036
diabetes mellitus (35901) 35901
glucose tolerance test (33471) 33471
proteins (32107) 32107
time factors (31793) 31793
insulin - metabolism (30665) 30665
glucose - pharmacology (29890) 29890
enzymes (29264) 29264
hyperglycemia (28597) 28597
blood glucose (27110) 27110
physiology (27013) 27013
expression (26408) 26408
insulin-resistance (25835) 25835
adolescent (25669) 25669
health aspects (24049) 24049
kinetics (23597) 23597
pregnancy (23254) 23254
body mass index (22715) 22715
oxidative stress (22474) 22474
biotechnology & applied microbiology (22470) 22470
pharmacology & pharmacy (22317) 22317
cell biology (21485) 21485
gene expression (20420) 20420
nutrition & dietetics (19983) 19983
diet (19959) 19959
research article (19514) 19514
neurosciences (19151) 19151
body weight (18858) 18858
insulin secretion (18674) 18674
diabetes mellitus, type 2 - blood (18531) 18531
risk (18341) 18341
studies (18283) 18283
fasting (17875) 17875
care and treatment (17788) 17788
rodents (17744) 17744
liver - metabolism (17740) 17740
disease (17420) 17420
mellitus (17298) 17298
blood pressure (17168) 17168
metabolic syndrome (16644) 16644
medicine (16569) 16569
prevalence (16487) 16487
hypoglycemic agents - therapeutic use (16479) 16479
liver (16373) 16373
diabetes mellitus, type 2 - drug therapy (16307) 16307
rats, wistar (16287) 16287
cells, cultured (16279) 16279
blood sugar (16252) 16252
medicine, general & internal (16092) 16092
insulin - pharmacology (16002) 16002
medicine, research & experimental (15955) 15955
inflammation (15904) 15904
child (15821) 15821
rats, sprague-dawley (15758) 15758
homeostasis (15683) 15683
medical research (15505) 15505
lipids (15311) 15311
diabetes therapy (15191) 15191
hypoglycemia (15179) 15179
apoptosis (14916) 14916
mortality (14878) 14878
phosphorylation (14657) 14657
fermentation (14648) 14648
cholesterol (14624) 14624
cells (14477) 14477
medicine & public health (14262) 14262
exercise (14222) 14222
microbiology (14202) 14202
hypertension (14180) 14180
in vitro techniques (14180) 14180
triglycerides - blood (14106) 14106
multidisciplinary sciences (13884) 13884
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (66) 66
Online Resources - Online (64) 64
University Archives - Archives (16) 16
Collection Dvlpm't (Acquisitions) - Vendor file (10) 10
Gerstein Science - Periodical Stacks (7) 7
Engineering & Comp. Sci. - Stacks (6) 6
Gerstein Science - Theses (6) 6
UTL at Downsview - May be requested (5) 5
UofT at Mississauga - Stacks (5) 5
Gerstein Science - Bindery (4) 4
Earth Sciences (Noranda) - Stacks (2) 2
Gerstein Science - Circulation Desk (2) 2
Physics - Theses (2) 2
Scarborough Hospital - General (2) 2
St. Michael's Hospital - Periodical Stacks (2) 2
St. Michael's Hospital - Storage (2) 2
UofT at Scarborough - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Collection Dvlpm't (Acquisitions) - Stacks (1) 1
Law (Bora Laskin) - Stacks (1) 1
Markham Stouffville Hospital - Stacks (1) 1
Mt Sinai Hospital - Pathology (1) 1
New College (Ivey) - Stacks (1) 1
OISE - Curriculum Resources (1) 1
Providence Healthcare - Stacks (1) 1
St Josephs Health Centre - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Trillium Health Centre - Stacks (1) 1
UofT at Mississauga - Oversize (1) 1
West Park Healthcare Centre - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (698222) 698222
German (11405) 11405
Japanese (9285) 9285
French (6375) 6375
Russian (5496) 5496
Chinese (4180) 4180
Spanish (3416) 3416
Italian (2684) 2684
Portuguese (2532) 2532
Polish (1538) 1538
Korean (997) 997
Czech (936) 936
Hungarian (407) 407
Dutch (319) 319
Ukrainian (290) 290
Swedish (285) 285
Danish (260) 260
Turkish (258) 258
Romanian (255) 255
Norwegian (200) 200
Bulgarian (196) 196
Persian (169) 169
Slovak (168) 168
Serbian (106) 106
Finnish (101) 101
Croatian (85) 85
Indonesian (69) 69
Hebrew (62) 62
Arabic (27) 27
Lithuanian (18) 18
Bosnian (14) 14
Icelandic (12) 12
Urdu (11) 11
Slovenian (10) 10
Afrikaans (8) 8
Greek (7) 7
Malay (4) 4
Catalan (3) 3
Hindi (3) 3
Welsh (3) 3
Macedonian (2) 2
Armenian (1) 1
Belarusian (1) 1
Breton (1) 1
Chamorro (1) 1
Estonian (1) 1
Latvian (1) 1
Northern Sami (1) 1
Thai (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Diabetes technology & therapeutics, ISSN 1520-9156, 1999
Journal
Scientific reports, ISSN 2045-2322, 2013, Volume 3, Issue 1, p. 1377
Journal Article
British journal of pharmacology, ISSN 0007-1188, 03/2012, Volume 165, Issue 5, pp. 1361 - 1374
BACKGROUND AND PURPOSE Pentoxifylline is in clinical trials for non‐alcoholic fatty liver disease and diabetic nephropathy. Metabolic and hepatic effects of... 
glucose | ChREBP | pentoxifylline | methylxanthine | fatty liver | drug‐induced liver injury | obesity | drug-induced liver injury | TRIGLYCERIDE TRANSFER PROTEIN | ELEMENT-BINDING PROTEIN | FACTOR-KAPPA-B | NONALCOHOLIC STEATOHEPATITIS | DIET-INDUCED OBESITY | PARTIAL LEPTIN DEFICIENCY | CYCLIC-AMP | IN-VIVO | GENE-EXPRESSION | PHARMACOLOGY & PHARMACY | METABOLIC-DISORDERS | Glucose Transporter Type 2 - genetics | Humans | Intestinal Absorption - drug effects | Male | Adipocytes - drug effects | Glycolysis - drug effects | Jejunum - metabolism | Glycolysis - genetics | Jejunum - drug effects | Inflammation - metabolism | Lipogenesis - genetics | Liver - drug effects | Pentoxifylline - pharmacology | Biomarkers - metabolism | Fatty Liver - metabolism | Liver - metabolism | Biomarkers - blood | Blood Glucose - drug effects | Cell Line, Tumor | Glucose - metabolism | Blood Glucose - genetics | Mice, Obese | Transaminases - blood | Mice | Oxidative Stress - drug effects | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - genetics | Glucose Tolerance Test - methods | Diabetes Mellitus, Type 2 - metabolism | Obesity - genetics | Glucose Transporter Type 2 - metabolism | Sodium-Glucose Transporter 1 - genetics | Glycolysis - physiology | Lipids - blood | Sodium-Glucose Transporter 1 - metabolism | Nuclear Proteins - genetics | Sterol Regulatory Element Binding Protein 1 - metabolism | Fatty Liver - genetics | Mice, Inbred C57BL | Oxidative Stress - genetics | Glucose - genetics | Nuclear Proteins - metabolism | Transcription Factors - genetics | Obesity - metabolism | Transcription Factors - metabolism | Animals | Intestinal Absorption - genetics | Sterol Regulatory Element Binding Protein 1 - genetics | Adipocytes - metabolism | Lipogenesis - drug effects | Triglycerides - blood | Inflammation - genetics | Oxidative Stress | Biological Markers | Liver | Lipids | Adipocytes | Glucose | Intestinal Absorption | Life Sciences | Jejunum | Diabetes Mellitus, Type 2 | Lipogenesis | Pharmaceutical sciences | Obesity | Glucose Tolerance Test | Glucose Transporter Type 2 | Sodium-Glucose Transporter 1 | Blood Glucose | Inflammation | Triglycerides | Pharmacology | Nuclear Proteins | Pentoxifylline | Fatty Liver | Transaminases | Glycolysis | Transcription Factors | Sterol Regulatory Element Binding Protein 1 | Research Papers
Journal Article
PloS one, ISSN 1932-6203, 02/2012, Volume 7, Issue 2, p. e30555
Background: Canagliflozin is a sodium glucose co-transporter (SGLT) 2 inhibitor in clinical development for the treatment of type 2 diabetes mellitus (T2DM).... 
SELECTIVE SGLT2 INHIBITOR | SODIUM | HOMEOSTASIS | HYPERGLYCEMIA | DAPAGLIFLOZIN | TRANSPORTERS | MULTIDISCIPLINARY SCIENCES | INSULIN-SECRETION | COTRANSPORTER | PROXIMAL TUBULAR CELLS | T-1095 | Thiophenes - therapeutic use | Diabetes Mellitus, Experimental - drug therapy | Humans | Body Weight - drug effects | Male | Muscle, Skeletal - metabolism | Muscle, Skeletal - cytology | Hyperglycemia - drug therapy | Sodium-Glucose Transporter 1 - genetics | Muscle, Skeletal - drug effects | Hyperglycemia - pathology | Sodium-Glucose Transport Proteins - metabolism | Glucosides - therapeutic use | Weight Gain - drug effects | Sodium-Glucose Transporter 1 - metabolism | Diabetes Mellitus, Experimental - metabolism | Kidney - physiopathology | Sodium-Glucose Transport Proteins - genetics | CHO Cells | Sodium-Glucose Transporter 2 - genetics | Cricetinae | Glucose Tolerance Test | Kidney - drug effects | Sodium-Glucose Transporter 2 - metabolism | Mice, Inbred C57BL | Cells, Cultured | Rats | Sodium-Glucose Transporter 2 - antagonists & inhibitors | Hyperglycemia - metabolism | Rats, Zucker | Animals | Canagliflozin | Diabetes Mellitus, Experimental - pathology | Mice, Obese | Mice | Blood Glucose - metabolism | Type 2 diabetes | Glucose metabolism | Obesity | Blood sugar | Analysis | Body weight | Glycosylated hemoglobin | Diabetes therapy | Cell culture | Animal models | Renal function | Laboratories | Liver | Homeostasis | Fuel consumption | Diabetic neuropathy | Glucose | Oocytes | Hyperglycemia | Rodents | Hemoglobin | Glucose transporter | Excretion | Kidneys | Secretion | Research & development--R&D | Diabetes mellitus | Pharmacology | Insulin | Body weight gain | Myoblasts | Beta cells | Sodium | Weight reduction | Insulin resistance | Diabetes | Mutation | Transporter | Kidney transplantation | Pharmaceuticals | Research & development | R&D
Journal Article
by Pogue, Janice and Riddle, Matthew C and Chazova, I and Gilbert, R and Gomis, R and Pīrāgs, V and Bogaty, P and Corson, M and Harper, W.L and Cukierman-Yaffee, T and MacRae, S and Alvarez, N and Amuchastegui, M and Bello, F and Caccavo, A and Calveira, M and Camino, A and Cardone, M and Corinaldesi, F and Crespo, C and Fares Taie, A and Fernandez, A and Ferrari, N and Gutierrez, N and Hasbani, E and Hrabar, A and Lobo Marquez, L and Lugo, M and Mainini, S and Manzano, R and Mendez, N and Odetto, I and Polari, P and Ramirez, A and Sanchez, R and Smith Casabella, T and Streitenberger, P and Villamil, A and Amerena, J and Farshid, A and Lefkovits, J and O'Neal, D and Poynten, A and Simpson, R and Teede, H and Tiong, F and Waddell-Smith, K and Blocher, J and Brath, H and Breuss, J and Jankovic, V and Kann, T and Placher-Sorko, G and Sonnenfeld, M and Vetter, B and Wallner, F and Lazareva, I and Delana, J and Feitosa, G and Garcia, V and Kanedlai, N and Mothe, F and Ninno, T and Oliveira, C and Oliveira, O and Roldan, F and Bailey, A and Belanger, A and Carlson, B and Chagnon, P and Chessex, C and Crepeau, J and Dube, F and Gosselin, G and Harper, W and Ho, K and Hramiak, I and Hutchinson, A and Langlois, M and Lavoie, M and Mercier, M and Nawaz, S and O'Keefe, D and Pruneau, G and Raby, K and Richard, C and Steinson, D and VanRossum, N and Warnica, W and Galloso, R and Stockins, B and Chen, Y and Gao, X and Ji, L and Jia, W and Li, Q and Li, Y and Ling, Y and Lu, B and Peng, Y and ... and unav and The ORIGIN Trial Investigators and ORIGIN Trial Investigators
The New England journal of medicine, ISSN 1533-4406, 2012, Volume 367, Issue 4, pp. 319 - 328
In this study with a 2-by-2 factorial design, patients with cardiovascular risk factors and dysglycemia or type 2 diabetes received insulin glargine or... 
DIABETES-MELLITUS | MEDICINE, GENERAL & INTERNAL | GLYCEMIC CONTROL | THERAPY | GLARGINE | GLUCOSE CONTROL | DISEASE | RISK | PEOPLE | ENDOTHELIAL FUNCTION | BETA-CELL FUNCTION | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Cholesterol - blood | Humans | Middle Aged | Male | Incidence | Glucose Intolerance - drug therapy | Cardiovascular Diseases - epidemiology | Female | Drug Therapy, Combination | Hypoglycemia - chemically induced | Diabetes Mellitus, Type 2 - complications | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Fasting | Blood Glucose - analysis | Double-Blind Method | Proportional Hazards Models | Hospitalization | Glucose Intolerance - complications | Insulin, Long-Acting - adverse effects | Insulin Glargine | Insulin, Long-Acting - therapeutic use | Intention to Treat Analysis | Triglycerides - blood | Fatty Acids, Omega-3 - therapeutic use | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Type 2 diabetes | Complications and side effects | Care and treatment | Insulin glargine | Patient outcomes | Causes of | Cardiovascular diseases | Risk factors | Myocardial infarction | Fees & charges | Cerebral infarction | Medical research | Stroke | Heart attacks | Statistical analysis | Diabetes mellitus | Glucose | Hypoglycemia | Fatty acids | Insulin | Glucose tolerance | Insulin resistance | Microvasculature | Diabetes | Diabetes mellitus (non-insulin dependent) | Heart diseases | Drug dosages | Cardiovascular Diseases | Insulin, Long-Acting | Blood Glucose | Triglycerides | Glucose Intolerance | Cholesterol | Life Sciences | Hypoglycemic Agents | Diabetes Mellitus, Type 2 | Fatty Acids, Omega-3
Journal Article
Diabetologia, ISSN 1432-0428, 2018, Volume 61, Issue 10, pp. 2079 - 2086
Sodium–glucose cotransporters SGLT1 (encoded by SGLT1, also known as SLC5A1) and SGLT2 (encoded by SGLT2, also known as SLC5A2) are important mediators of... 
Heart failure | Intestinal glucose transport | Type 2 diabetes | Human Physiology | Sodium–glucose cotransporter | Metabolic Diseases | Internal Medicine | Chronic kidney disease | Review | Drug development | Medicine & Public Health | Type 1 diabetes | Inhibitor | Renal glucose transport | KIDNEY-DISEASE | OXYGEN-CONSUMPTION | GLOMERULAR HYPERFILTRATION | DIABETES-MELLITUS | GLUCAGON-LIKE PEPTIDE-1 | ENDOCRINOLOGY & METABOLISM | Sodium-glucose cotransporter | CARDIOVASCULAR-DISEASE | POSTPRANDIAL HYPERGLYCEMIA | DOUBLE-BLIND | IMPROVED GLYCEMIC CONTROL | Sodium-Glucose Transporter 1 - antagonists & inhibitors | Intestinal Mucosa - metabolism | Sodium-Glucose Transporter 2 - metabolism | Humans | Sodium-Glucose Transporter 2 Inhibitors - pharmacology | Diabetes Mellitus, Type 1 - metabolism | Diabetes Mellitus, Type 2 - metabolism | Diabetes Mellitus, Type 1 - drug therapy | Kidney - metabolism | Animals | Drug Design | Glucose - metabolism | Diabetic Ketoacidosis - prevention & control | Mice | Mutation | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Phlorhizin - pharmacology | Disease Models, Animal | Glucose metabolism | Chronic kidney failure | Analysis | Genetically modified organisms | Drug discovery | Glucose | Drug approval | Dextrose | Cardiovascular system | Animal models | Kidneys | Cloning | Diabetes mellitus | Glucose transport | Sodium | Intestine | Renal failure | Malabsorption | Mathematical models | Galactose | Diabetes mellitus (non-insulin dependent) | Heart diseases
Journal Article